Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application

Author： Betti M.   Voltan R.   Marchisio M.   Mantovani I.   Boarini C.   Nappi F.   Ensoli B.   Caputo A.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.19, Iss.25, 2001-05, pp. : 3408-3419

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospects and challenges for prophylactic and therapeutic HIV vaccines

By Klein M.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 616-619

Elsevier

Access to resources Recommend Favorite

Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application

By Caputo A.   Betti M.   Altavilla G.   Bonaccorsi A.   Boarini C.   Marchisio M.   Butto S.   Sparnacci K.   Laus M.   Tondelli L.   Ensoli B.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2303-2317

Elsevier

Access to resources Recommend Favorite

Rational development of prophylactic HIV vaccines based on structural and regulatory proteins

By Mooij P.   Heeney J.L.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 304-321

Elsevier

Access to resources Recommend Favorite

Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response

By Morris C.B.   Thanawastien A.   Sullivan D.E.   Clements J.D.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 12-15

Elsevier

Access to resources Recommend Favorite

V-1 Immunitor: oral therapeutic AIDS vaccine with prophylactic potential

By Jirathitikal V.   Sooksathan P.   Metadilogkul O.   Bourinbaiar A.S.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 624-628

Elsevier

Access to resources Recommend Favorite